Publications by authors named "Jason R Ruth"

Claim this Profile
D
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
Sheila K Pierson, Sushila Shenoy, Ana B Oromendia, Alexander M Gorzewski, Ruth-Anne Langan Pai, Jason R Ruth

Blood Adv· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular dormancy in minimal residual disease following targeted therapy.
Jason R Ruth, Dhruv K Pant, Tien-Chi Pan, Hans E Seidel, Sanjeethan C Baksh

Breast Cancer Res· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.
Christopher S Nabel, Stephen Sameroff, Dustin Shilling, Daisy Alapat, Jason R Ruth

PLoS One· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6-blockade-refractory idiopathic multicentric Castleman disease.
David C Fajgenbaum, Ruth-Anne Langan, Alberto Sada Japp, Helen L Partridge, Sheila K Pierson, Jason R Ruth

J Clin Invest· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The collaborative network approach: a new framework to accelerate Castleman's disease and other rare disease research.
David C Fajgenbaum, Jason R Ruth, Dermot Kelleher, Arthur H Rubenstein

Lancet Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idiopathic multicentric Castleman's disease: a systematic literature review.
Amy Y Liu, Christopher S Nabel, Brian S Finkelman, Jason R Ruth, Razelle Kurzrock

Lancet Haematol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
Gregory V Kryukov, Frederick H Wilson, Jason R Ruth, Joshiawa Paulk, Aviad Tsherniak

Science· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Taking Control of Castleman Disease: Leveraging Precision Medicine Technologies to Accelerate Rare Disease Research.
Samantha Kass Newman, Raj K Jayanthan, Grant W Mitchell, Jossie A Carreras Tartak, Michael P Croglio, Jason R Ruth

Yale J Biol Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.
Yi Feng, Tien-Chi Pan, Dhruv K Pant, Kristi R Chakrabarti, James V Alvarez, Jason R Ruth

Cancer Discov· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments.
Mark A LaBarge, Celeste M Nelson, Rene Villadsen, Agla Fridriksdottir, Jason R Ruth

Integr Biol (Camb)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis